Abstract: A method of providing native scalable management of a fleet of managed devices, which includes establishing a Trust Community, which includes a sub-set of the managed devices, organizing the Trust Community, configuring one of the managed devices in the organized Trust Community as a Root Device to publish files via a file sharing function, adding the Root Device to a distribution profile stored in a database, creating or downloading files via the Root Device, and sharing the files with other devices in the organized Trust Community via the Root Device. Any devices on hold or offline are placed in a temporary working area for reorganizing. Download and install schedules are set up on a per device or a bulk basis according to policies. Files are placed into a staging area before re-distribution and checked for security, integrity, and/or completeness via checksums, digitally signed certificates, and/or internal structure checks.

Abstract: An audio mixer system and method is provided. The audio mixer system includes an audio interface, an audio signal processor, and a control circuit. The control circuit is configured to recognize a source type of an audio signal at the audio interface based on analyzing the audio signal. The control circuit is configured to control a setting of a signal path of the audio signal from an input of the audio interface through the audio signal processor to an output of the audio interface based on the recognized source type.

Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.

Abstract: A method and system (1) for incorporating legacy systems in a service oriented architecture (SOA) includes decoupling legacy system business services from legacy system data services by creating, from the legacy system business services and data services, a set of (e.g. Java WebSphere®) SOA business services (5a-5c) for transactions and (e.g. DB2) stored procedures (7a-7d) for SOA data services. The business services are constructed from one or more data services and the transactional integrity of the transaction is maintained, in use. The stored procedures may be written to a transaction log and a check made to verify that all of the stored procedures from which the business service is constructed have been written to the log.

Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.

Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.

Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.

Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.

Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.

Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.

Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.

Abstract: A method and system (1) for incorporating legacy systems in a service oriented architecture (SOA) includes decoupling legacy system business services from legacy system data services by creating, from the legacy system business services and data services, a set of (e.g. Java WebSphere®) SOA business services (5a-5c) for transactions and (e.g. DB2) stored procedures (7a-7d) for SOA data services. The business services are constructed from one or more data services and the transactional integrity of the transaction is maintained, in use. The stored procedures may be written to a transaction log and a check made to verify that all of the stored procedures from which the business service is constructed have been written to the log.

Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.

Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.

Abstract: The invention relates to compounds of general formula (I); in which R is an amino or guanidino group; R2 is acetyl or trifluoroacetyl; and n is an integer from 10 to 18 or a pharmaceutically acceptable derivative thereof, methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection.

Abstract: Nano-scale DMC catalyst complexes are highly active alkylene oxide polymerization catalysts. Thy show a greatly improved ability to catalyze the formation of EO-capping onto secondary hydroxyl-terminated polyethers. The catalysts can be prepared by precipitation in the dispersed adequous phase of a water-in-oil emulsion.

Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.

Abstract: This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals, as well as novel intermediates useful in the preparation of the compounds of formula I.

Abstract: The present invention relates to novel tyrosine kinase (TK) inhibitors in the form of prodrugs.

Abstract: The invention relates to a multimeric compound or a pharmaceutically acceptable salt or derivative thereof which comprises three or more neuraminidase-binding groups attached to a spacer or linking group, in which the neuraminidase-binding group is a compound which binds to the active site of influenza virus neuraminidase, but is not cleaved by the neuraminidase. The invention also relates to processes for the preparation of the multimeric compound defined above, pharmaceutical compositions containing them or methods for the treatment and/or prophylaxis of a viral infection involving them.